Article
microRNA-34 family and treatment of cancers with mutant or wild-type p53 (Review).
International journal of oncology - 1 May 2011
Wong May Y W, Yu Yan, Walsh William R, Yang Jia-Lin
Abstract excerpt
In the last decade, microRNAs (miRNAs; small noncoding RNA molecules) as post-transcriptional regulators have been a hotspot in research for their involvement in biological processes and tumour development. However, there have been few reviews focusing on a single miRNA family. The dysregulation of miRNAs appears to play a crucial role in cancer pathogenesis where they exert their effect as oncogenes or as tumour...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
